Clinical trials for Colon cancer
189 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 3
Colon cancer
Rectal cancer
#NCT06997497
#2024-517232-22-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
KRAS G12C
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
9 recruiting sites
Merck Sharp & Dohme LLC
Phase 3
Colon cancer
Rectal cancer
#NCT06662786
#2024-513852-13-00
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded genetic anomalies
BRAF
HER2
KRAS G12C
KRAS non G12C
MSI/dMMR
NRAS
7 recruiting sites
Janssen
Phase 3
Colon cancer
Rectal cancer
#NCT02885753
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
83 recruiting sites
Fédération Francophone de Cancérologie Digestive
Phase 3
Colon cancer
#NCT02355379
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Surgery
Excluded previous treatments at advanced or metastatic stage
Chemotherapy
113 recruiting sites
Fédération Francophone de Cancérologie Digestive
Phase 3
Colon cancer
Rectal cancer
#NCT04120701
#2024-515297-27-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Localized
Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Surgery
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Surgery
Excluded previous treatments at localized stage
Chemotherapy
Radiotherapy
Excluded previous treatments at advanced or metastatic stage
Chemotherapy
Radiotherapy
123 recruiting sites
CHU Dijon
Phase 3
Lung cancer
Colon cancer
Rectal cancer
Pancreas cancer
Sarcoma and GIST
#NCT06332274
#2023-503316-33-00
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Soft tissue sarcoma
Required disease stage
Localized
Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery
Chemotherapy
Required previous treatments at advanced or metastatic stage
Surgery
Chemotherapy
Excluded genetic anomalies
EGFR
Excluded previous treatments at localized stage
Immunotherapy
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
4 recruiting sites
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3
Colon cancer
Rectal cancer
#NCT06197425
#2023-505046-26-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery
Chemotherapy
4 recruiting sites
Centre Hospitalier Universitaire Dijon
Phase 3
Colon cancer
Rectal cancer
#NCT06252649
#2022-502352-31-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic
Required genetic anomalies
KRAS G12C
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at localized stage
Targeted therapy
Excluded previous treatments at advanced or metastatic stage
Targeted therapy
16 recruiting sites
Amgen
Phase 3
Colon cancer
Rectal cancer
#NCT04089631
#2018-003691-12
Phase de sélection
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery
Excluded genetic anomalies
MSI/dMMR
5 recruiting sites
Phase 3
Colon cancer
#NCT05855200
#2023-503265-27-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Localized
Locally Advanced
Required genetic anomalies
MSI/dMMR
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded genetic anomalies
MSS/pMMR
9 recruiting sites
GlaxoSmithKline